Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 30Neoplasms 12Overweight 8Breast Neoplasms 8Dyspnea 7Sexual Dysfunction, Physiological 5Mucositis 5Endometrial Neoplasms 5Pediatric Obesity 4Motor Activity 4Diabetes Mellitus, Type 2 4Weight Loss 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Insulin Resistance 3Uterine Cervical Neoplasms 2Syndrome 2Stomatitis 2Pulmonary Disease, Chronic Obstructive 2Pain 2Obesity-Related Malignant Neoplasm 2Obesity, Morbid 2Leukemia 2Infertility 2Fatigue 2Endometrial Hyperplasia 2Disease 2Diabetes Mellitus 2Cough 2Constipation 2

Interventions

naldemedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Other × 90 days × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡